FDA is expected today to authorize Moderna's coronavirus vaccine for emergency use in the United States, but is the vaccine truly safe and effective? Advisory Board's Brandi Greenberg dives deep into the details—including how Moderna's vaccine stacks up to Pfizer's vaccine authorized last week.
Moody's Investors Service in a report released last week said it has a negative financial outlook for nonprofit hospitals for 2021, as hospitals likely will continue to see constrained revenue and rising expenses because of America's coronavirus epidemic. Advisory Board's Christopher Kerns explains why some hospitals are better poised to weather the epidemic than others.
An FDA advisory panel on Thursday recommended the agency authorize the emergency use of Moderna's coronavirus vaccine candidate—a decision which makes it likely the inoculation will receive an emergency use authorization as early as Friday.
Facebook and Twitter announce they will tamp down on Covid-19 vaccine misinformation, two health care workers in Alaska experience adverse reactions to Pfizer and BioNTech's Covid-19 vaccine, and more.
A little over a year ago, Daily Briefing began tracking news of a "mysterious pneumonia" in Wuhan, China. Little did we know it was the start to one of the most difficult and important years in recent history—one that would expose tough lessons for public health in America. Here are the biggest lessons from a year covering the pandemic, according to Daily Briefing's Ashley Fuoco Antonelli.
Under the agreement, Eli Lilly will purchase Prevail for nearly $1 billion to expand its presence in gene therapy, which has become a lucrative area of drug research used to develop treatments for neurodegenerative diseases such as Parkinson's disease, in today's bite-sized hospital and health industry news from Georgia, New York, Indiana, and Pennsylvania.
